Anti-Mouse CD8a Antibody(YTS 169.4, Rat IgG2b) | PA007166.r2b
Recombinant rat IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant rat IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant anti-mouse CD8a monoclonal antibodies from the variable region sequences of the rat anti-mouse CD8a monoclonal antibody (clone number: YTS 169.4) are produced from mammalian cells and good for in vitro and in vivo studies.
Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant anti-human CD3 / CD3 bispecific antibodies have the same variable region sequences as the mouse anti-human CD3 antibody (clone number: OKT3) and the mouse anti-human CD3 antibody (clone number: SP34-2). The recombinant mouse IgG2a...
Recombinant anti-human CD3 / CD3 bispecific antibodies have the same variable region sequences as the mouse anti-human CD3 antibody (clone number: OKT3) and the mouse anti-human CD3 antibody (clone number: SP34-2). The recombinant mouse IgG2a...
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Adalimumab biosimilar CHO stable cell line is available for licensing to manufacture the adalimumab biosimilar protein. The research grade adalimumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant Mouse IgG1 isotype controls and Recombinant Hamster IgG2 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Infliximab biosimilar CHO stable cell line is available for licensing to manufacture the Infliximab biosimilar protein. The research grade infliximab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available.